{
    "2021-06-21": [
        [
            {
                "time": "2018-03-15",
                "original_text": "AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "outpaces",
                        "stock market gains"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "UPDATE 1-U.S. Supreme Court rebuffs AbbVie appeal in patent fight involving AndroGel drug",
                "features": {
                    "keywords": [
                        "U.S. Supreme Court",
                        "rebuffs",
                        "AbbVie",
                        "patent fight",
                        "AndroGel drug"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}